Objective: Process evaluation of a worksite intervention in which employees were offered $750 to complete a cessation program and to quit smoking.
Methods: Awareness and attitudes about financial incentives were assessed following a randomized controlled trial of 878 smokers at a US-based company.
Results: Cessation program attendance was higher in incentive group versus control (20.2% vs 7.1%, P < 0.01). Most quitters (69.8%) in the incentive group who were already motivated to quit and reported that they would have quit for less money, said incentives were "not at all" or only "somewhat" important. Most nonquitters in the incentive group reported that even $1500 would not have motivated them to quit.
Conclusions: Financial incentives are ineffective at motivating some smokers to quit. Internal motivation and readiness to quit need to be sufficiently high for relatively modest incentives to be effective.
Why are financial incentives not effective at influencing some smokers to quit? Results of a process evaluation of a worksite trail assessing the efficacy of financial incentives for smoking cessation
Kim, A., Kamyab, K., Zhu, J., & Volpp, K. (2011). Why are financial incentives not effective at influencing some smokers to quit? Results of a process evaluation of a worksite trail assessing the efficacy of financial incentives for smoking cessation. Journal of Occupational and Environmental Medicine, 53(1), 62-67. https://doi.org/10.1097/JOM.0b013e31820061d7, https://doi.org/10.1097/JOM.0b013e31820061d7
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Meet the Experts
View All ExpertsRecent Publications
Article
What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders
Article
Grandi Byen-supporting child growth and development through integrated, responsive parenting, nutrition and hygiene
Article
Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions
Article